Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3-Reference-Cited by-同舟云学术

Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3

Published:2001-12-01 Issue:6 Volume:60 Page:1399-1406
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Thummel Kenneth E.,Brimer Cynthia,Yasuda Kazuto,Thottassery Jaideep,Senn Tauri,Lin Yvonne,Ishizuka Hitoshi,Kharasch Evan,Schuetz John,Schuetz Erin

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference49 articles.

1. Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.;Barwick;Mol Pharmacol,1996

2. Immunocytochemical Detection of 1,25-Dihydroxyvitamin D Receptors in Normal Human Tissues*

3. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

4. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

5. SXR, a novel steroid and xenobioticsensing nuclear receptor

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The activating enzymes of vitamin D metabolism (25- and 1α-hydroxylases);Feldman and Pike' s Vitamin D;2024

2. Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study;Cells;2023-04-27

3. Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin–Drug Interactions Exist?;Life;2022-10-20

4. Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment;Cytokine & Growth Factor Reviews;2022-10

5. The Impact of Suboptimal 25‐Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease;The Journal of Clinical Pharmacology;2022-07-09